-
1دورية أكاديمية
المؤلفون: Lecis D; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy., Prandi FR; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.; Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA., Barone L; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy., Belli M; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.; Cardiovascular Imaging Unit, San Raffaele Scientific Institute, 20132 Milan, Italy., Sergi D; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy., Longo S; Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy., Muscoli S; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy., Romeo F; Faculty of Medicine, UniCamillus-Saint Camillus International University of Health and Medical Sciences, 00131 Rome, Italy., Federici M; Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy., Lerakis S; Division of Cardiology, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA., Barillà F; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133 Rome, Italy.
المصدر: Biomolecules [Biomolecules] 2023 Nov 23; Vol. 13 (12). Date of Electronic Publication: 2023 Nov 23.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X (Electronic) Linking ISSN: 2218273X NLM ISO Abbreviation: Biomolecules Subsets: MEDLINE
مواضيع طبية MeSH: Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/metabolism , Cardiovascular Diseases*/drug therapy , Atherosclerosis*/drug therapy, Humans ; Hypoglycemic Agents/therapeutic use ; Glucagon-Like Peptide-1 Receptor Agonists ; Glucagon-Like Peptide-1 Receptor/metabolism
-
2دورية أكاديمية
المؤلفون: Sergi D; Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy., Zauli E; Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy., Tisato V; Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy., Secchiero P; Department of Translational Medicine and LTTA Centre, University of Ferrara, 44121 Ferrara, Italy., Zauli G; King Khaled Eye Specialistic Hospital, Riyadh 11462, Saudi Arabia., Cervellati C; Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Feb 23; Vol. 24 (5). Date of Electronic Publication: 2023 Feb 23.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
مواضيع طبية MeSH: Dementia, Vascular* , Cerebrovascular Disorders* , Cardiovascular Diseases* , Atherosclerosis*, Humans ; Cholesterol, HDL ; Ceramides ; Prospective Studies ; Lipoproteins/metabolism ; Triglycerides
-
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.